Phoenix Financial’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.67M Sell
16,052
-34,024
-68% -$3.62M 0.02% 191
2025
Q4
$5.17M Hold
50,076
0.06% 130
2025
Q3
$4.52M Sell
50,076
-11,200
-18% -$981K 0.06% 134
2025
Q2
$5.39M Buy
61,276
+7,417
+14% +$643K 0.07% 125
2025
Q1
$4.99M Buy
53,859
+2,438
+5% +$220K 0.08% 124
2024
Q4
$4.52M Sell
51,421
-36,860
-42% -$3.33M 0.06% 140
2024
Q3
$8.47M Buy
88,281
+6,034
+7% +$573K 0.13% 98
2024
Q2
$7.61M Sell
82,247
-1,344
-2% -$120K 0.12% 102
2024
Q1
$7.67M Sell
83,591
-4,953
-6% -$434K 0.11% 95
2023
Q4
$7.3M Sell
88,544
-26,403
-23% -$2.07M 0.12% 86
2023
Q3
$9.26M Sell
114,947
-282,969
-71% -$22.8M 0.17% 70
2023
Q2
$31.3M Buy
397,916
+112,512
+39% +$8.81M 0.64% 39
2023
Q1
$22.2M Sell
285,404
-1,909,604
-87% -$147M 0.5% 44
2022
Q4
$171M Sell
2,195,008
-2,033
-0.1% -$150K 3.3% 5
2022
Q3
$149M Buy
2,197,041
+1,715
+0.1% +$126K 3.29% 5
2022
Q2
$169M Buy
2,195,326
+2,106,726
+2,378% +$164M 3.45% 4
2022
Q1
$7.09M Buy
+88,600
New +$6.78M 0.12% 118

Other funds holding PPH

Phoenix Financial's PPH Position: Q1 2026 in Review

Phoenix Financial reduced its VanEck Pharmaceutical ETF (PPH) stake by 68% in Q1 2026, selling an estimated $3.62M and leaving 16,052 shares worth $1.67M. The position accounts for 0.02% of the portfolio, ranked #191.

Phoenix Financial first reported a position in PPH in Q1 2022 and has held it in 17 quarters since. The position peaked at $171M in Q4 2022. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

  • Phoenix Financial held 16,052 shares of VanEck Pharmaceutical ETF worth $1.67M as of Q1 2026.
  • Phoenix Financial sold 34,024 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $3.62M.
  • VanEck Pharmaceutical ETF made up 0.02% of Phoenix Financial's portfolio in Q1 2026, its #191 holding.
  • Phoenix Financial first reported a position in VanEck Pharmaceutical ETF in Q1 2022 and has held it in 17 quarters since.
  • Phoenix Financial's VanEck Pharmaceutical ETF position peaked at $171M in Q4 2022.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Phoenix Financial's 13F filing for Q1 2026, filed 11 May 2026.